| The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape MME de Jong, Z Kellermayer, N Papazian, S Tahri, D Hofste Op Bruinink, ... Nature immunology 22 (6), 769-780, 2021 | 120* | 2021 |
| Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant TH Mouhieddine, AS Sperling, R Redd, J Park, M Leventhal, CJ Gibson, ... Nature communications 11 (1), 2996, 2020 | 118 | 2020 |
| Proteomic characterization of human multiple myeloma bone marrow extracellular matrix SV Glavey, A Naba, S Manier, K Clauser, S Tahri, J Park, MR Reagan, ... Leukemia 31 (11), 2426-2434, 2017 | 91 | 2017 |
| Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation AS Nam, N Dusaj, F Izzo, R Murali, RM Myers, TH Mouhieddine, J Sotelo, ... Nature genetics 54 (10), 1514-1526, 2022 | 72 | 2022 |
| The microenvironment in myeloma OC Lomas, S Tahri, IM Ghobrial Current opinion in oncology 32 (2), 170-175, 2020 | 67 | 2020 |
| Hofste Op Bruinink MME De Jong, Z Kellermayer, N Papazian, S Tahri D., Hoogenboezem, R., Sanders, MA, van de Woestijne, PC, Bos, PK …, 2021 | 60 | 2021 |
| Monoclonal gammopathy of undetermined significance (MGUS)—Not so asymptomatic after all OC Lomas, TH Mouhieddine, S Tahri, IM Ghobrial Cancers 12 (6), 1554, 2020 | 33 | 2020 |
| Pulmonary hypertension is a mild comorbidity in end-stage cystic fibrosis patients G Belle-van Meerkerk, MJ Cramer, JM Kwakkel-van Erp, MA Nugroho, ... The Journal of Heart and Lung Transplantation 32 (6), 609-614, 2013 | 27 | 2013 |
| Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma R Sklavenitis-Pistofidis, MP Aranha, RA Redd, J Baginska, ... Cancer Cell 40 (11), 1358-1373. e8, 2022 | 21 | 2022 |
| Intussusception during pregnancy after laparoscopic Roux-en-Y gastric bypass A Bokslag, J Jebbink, L De Wit, M Oudijk, L Ribbert, S Tahri, ... Case Reports 2014, bcr2014205357, 2014 | 18 | 2014 |
| Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia S Tahri, TH Mouhieddine, R Redd, L Lampe, KI Nilsson, H El-Khoury, ... Blood Advances 6 (7), 2230-2235, 2022 | 13 | 2022 |
| Extreme body mass index and survival in newly diagnosed multiple myeloma patients UA Shah, K Whiting, S Devlin, R Ershler, B Kanapuru, DJ Lee, S Tahri, ... Blood Cancer Journal 13 (1), 13, 2023 | 6 | 2023 |
| In Vivo Genome-Wide Crispr Library Screen in a Xenograft Mouse Model of Tumor Growth and Metastasis of Multiple Myeloma Y Shen, S Manier, J Park, Y Mishima, M Capelletti, AM Roccaro, D Huynh, ... Blood, The Journal of the American Society of Hematology 128 (22), 1137-1137, 2016 | 5 | 2016 |
| An IL-1β-driven neutrophil–stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma MME de Jong, C Fokkema, N Papazian, Á Czeti, MK Appelman, ... Nature Immunology, 1-14, 2024 | 4 | 2024 |
| Stromal Cell-Activated Bone Marrow Neutrophils Provide BAFF in Newly Diagnosed and Treated Multiple Myeloma MME de Jong, C Fokkema, N Papazian, T van Heusden, M Vermeulen, ... Blood 140 (Supplement 1), 4181-4182, 2022 | 2 | 2022 |
| Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy S Tahri, MME de Jong, C Fokkema, N Papazian, Z Kellermayer, ... Blood 140 (Supplement 1), 9982-9984, 2022 | 2 | 2022 |
| Single-cell RNA-sequencing identifies immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma R Sklavenitis-Pistofidis, AK Dutta, S Ujwary, RA Redd, A Savell, L Fléchon, ... Blood 138, 330, 2021 | 2 | 2021 |
| Clinical outcomes and evolution of clonal hematopoiesis in patients with newly diagnosed multiple myeloma TH Mouhieddine, C Nzerem, R Redd, A Dunford, M Leventhal, ... Cancer Research Communications 3 (12), 2560-2571, 2023 | 1 | 2023 |
| An IL-1β driven neutrophil-stromal cell axis fosters a BAFF-rich microenvironment in multiple myeloma MME de Jong, C Fokkema, N Papazian, T van Heusden, M Vermeulen, ... bioRxiv, 2023.03. 03.530773, 2023 | 1 | 2023 |
| Immune-mediated tumor control in the 5TGM1 transfer model of multiple myeloma Z Kellermayer, S Tahri, MME de Jong, N Papazian, C Fokkema, ... bioRxiv, 2023.01. 18.524505, 2023 | 1 | 2023 |
